Should You Buy the Dip in uCloudlink Group?

: UCL | uCloudlink Group Inc. ADR News, Ratings, and Charts

UCL – Shares of telecom company uCloudlink (UCL) have declined significantly since its initial public offering in June 2020. However, is it wise to buy the dip in the stock now as the company shows revenue growth? Let’s find out.

Mobile data traffic sharing marketplace uCloudlink Group (UCL - Get Rating) recently announced that it has entered into a definitive agreement with YA II PN, Ltd., to issue and sell convertible debentures in a principal amount of $5 million and intends to use the net proceeds for general corporate purposes. The company also expects total revenues for the fourth quarter of 2021 to be between $17.50 million and $18 million, representing a 2.9% to 5.9% year-over-year increase.

However, the stock has lost 14.1% over the past month and 36.6% over the past three months to close yesterday’s trading session at $1.70. In addition, it is currently trading 87.8% below its all-time high of $13.95, which it hit on April 26, 2021. Also, analysts expect its EPS to remain negative in fiscal 2022. So, UCL’s near-term prospects look uncertain.

Here’s what could influence UCL’s performance in the upcoming months:

Lower-Than-Industry Valuation

In terms of forward EV/S, UCL’s 0.30x is 87.5% lower than the industry average of 2.39x. Likewise, its forward P/S of 0.65x is 60.6% lower than the industry average of 1.66x.

Top Line Growth Doesn’t Translate into Bottom Line Improvement

For the fiscal third quarter ended September 30, 2021, UCL’s total revenues surged 7.4% year-over-year to $19.30 million. However, its total assets came in at $97.25 million for the period ended September 30, 2021, compared to $24.87 million for the period ended December 31, 2020. The company’s adjusted EBITDA loss grew 8% year-over-year to $5.40 million. Also, its adjusted net loss came in at $6 million, representing a 5.3% year-over-year increase.

Low Profitability

In terms of trailing-12-month CAPEX/Sales, UCL’s 1.71% is 54.7% lower than the industry average of 3.77%. Likewise, its trailing-12-month gross profit margin of 29.67% is 42% lower than the industry average of 51.16%. Moreover, the stock’s trailing-12-month ROCE, ROTC, and ROTA are negative compared to the industry averages of 9.87%, 4.29%, and 3.31%, respectively.

POWR Ratings Don’t Indicate Enough Upside

UCL has an overall rating of C, which equates to a Neutral in our POWR Ratings system. The POWR Ratings are calculated by taking into account 118 different factors, with each factor weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight different categories. UCL has a D grade for Quality, in sync with its lower-than-industry profitability ratios.

Moreover, the stock has a C grade for Momentum, consistent with its 71.8% loss over the past six months and 86.9% decline over the past year.

UCL is ranked #38 out of 52 stocks in the Industrial – Building Materials industry. Click here to access all of UCL’s ratings.

Bottom Line

UCL is currently trading below its 50-day and 200-day moving averages of $2.42 and $5.74, respectively, indicating a downtrend. So, it could be wise to wait for a better entry point in the stock.

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year


UCL shares were unchanged in after-hours trading Wednesday. Year-to-date, UCL has declined -74.96%, versus a -11.16% rise in the benchmark S&P 500 index during the same period.


About the Author: Nimesh Jaiswal


Nimesh Jaiswal's fervent interest in analyzing and interpreting financial data led him to a career as a financial analyst and journalist. The importance of financial statements in driving a stock’s price is the key approach that he follows while advising investors in his articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
UCLGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Trump or the Fed More Important to Stock Investors?

The S&P 500 (SPY) is flirting with new highs once again. But it is not very clear what is driving these stock price gains. That is why Steve Reitmeister shares his latest views including a market outlook, trading plan and top picks to stay on the right side of the action.

3 Robotics Stocks Powering the Future of Automation

Powered by rapid AI advancements, enhanced automation processes, and growing demand for commercial adoption, modern robotics is reshaping the automation landscape. Investors looking to capitalize on this momentum might find opportunities in Stryker (SYK), Fanuc Corporation (FANUY), and UiPath (PATH). Continue to read…

3 Pharmaceutical Stocks Betting Big on Weight Loss Drugs

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, pharmaceutical giants like Eli Lilly and Company (LLY), Novo Nordisk (NVO), and Amgen (AMGN) are betting big on next-generation weight loss treatments to dominate this booming market. Keeping reading...

3 "Forever Stocks" You Can Buy and Hold for Decades

Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in the economic and geopolitical spheres. In this volatile environment, investors may find value in fundamentally stable stocks like Microsoft (MSFT), Alphabet (GOOGL), and Johnson & Johnson (JNJ). Continue to read…

Investors in “Wait and See” Mode

Have you noticed that the S&P 500 (SPY) has been trading in a tight trading range of only 6,000 to 6,100 the past few weeks? Steve Reitmeister shares why this is happening along with a game plan for being on the right side of the market action. Read on for the full story...

Read More Stories

More uCloudlink Group Inc. ADR (UCL) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All UCL News